Voxelation is used as a novel method for three-dimensional imaging of gene expression in the brain
An important part of the results is the validation of the reproducibility of the method. By applying a microarray analysis of 5,000 genes to four individual samples of a single voxel (small cube) and using scatter-plots to analyze the results, the authors show excellent reproducibility of the results between individual samples. At the same time, the statistical analysis of the results from voxels using the smaller 2,000-gene array also revealed high reproducibility between and within the hemisections. The results illustrate the differences between gene expression in normal brain compared with brain affected by Alzheimer's disease. Analysis of the microarray data has identified two clusters of genes co-regulated in the two samples. Each cluster was positively correlated with itself and negatively correlated with the other cluster: for example, the genes U5-100K from cluster 1 and RNPS1 from cluster 2 have highly negatively correlated spatial expression patterns. It was suggested that this might be explained by similar functions of these proteins.
The comparison between normal and Alzheimer's brain revealed 34 differentially expressed genes. These included eight transcription-associated genes (for example, DRAP1 and TAF2F), five involved in signal transduction (for example, RAP2A and PRKCB1), three involved in modulating the cytoskeleton (for example, ICAAP-1A), two in respiration (for example, COX7B), two in redox reactions (for example, CCS), twelve unclassified genes (for example, LIMS1 and RAB2) and two novel genes. Singular value decomposition (SVD) analysis of the top 120 differentially expressed genes allowed identification of genes expressed specifically in cortex, caudate, hippocampus, and insular cortex. An exhaustive analysis of the non-coding regions of the correlated and anticorrelated genes was used to identify and compare the regulatory sequences. This analysis confirmed the presence of known regulatory sites.
Methodological innovations
Horizontal sections (hemisections) were divided into 24 voxels (small cubes). Some voxels were empty as a result of the difference between brain shape and the voxel grid. All voxels containing 50% biological material by volume were pooled with the neighboring voxels for analysis. Gene expression in each voxel was then analyzed using a 2,000 gene microarray, with RNA from the total hemisection as a control. Matrices correlating gene expression levels to the arbitrary scales were generated from the array data. These were used to identify genes co-expressed or differentially expressed between normal and diseased tissue. The microarray data were statistically analyzed using SVD analysis. This enabled the generation of regional maps of gene expression by sequential analysis (principal component analysis) of the expression patterns and correlation of gene expression with anatomical area.
Links
More information on the work is available from the Smith Lab website and Supplementary data to Genome Research 12:244-254 are available.
Conclusions
Brown et al. conclude that voxelation is a useful method for understanding how the three-dimensional structure of the brain develops. It is also the first step towards expression mapping of complex organs.
Reporter's comments
This method is revolutionary. By analyzing sufficient brain sections it is possible to obtain a full three-dimensional picture of gene expression in the brain. The method has an advantage over total brain microarray analysis as it allows identification of genes that are expressed at low level. The authors point out that higher-resolution voxelation maps will be more informative, but the technology has to improve before that is possible. These types of maps can also be applied to other tissues. For the analysis of diseased versus healthy brain, however, the use of age-matched controls is a better option than using significantly younger controls as there is then no possibility of skewed results as a result of lower gene expression resulting from a combination of disease and neuronal cell death resulting from age-related changes. 
